SINGAPORE, Aug. 13, 2012 /PRNewswire/ -- The occurrence of infectious diseases – vector and blood borne – is high in Asia Pacific countries due to the tropical climate. While limited healthcare budgets had prevented most countries in the region from investing on diagnosis, treatment and elimination protocols, improving economies as well as funding and grants from international organizations have seen the adoption of earlier diagnosis and treatment strategies in recent years.
New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), Asia Pacific Infectious Disease Diagnostics Market, expects the market to grow at 13.2 percent to reach revenues of $3,063.2 million by 2016. The study analyses the immunochemistry, molecular diagnostics and microbiology markets for the treatment of malaria, dengue, tuberculosis, HIV, hepatitis C, STI, influenza and pertussis.
As Asian countries position themselves as a popular medical tourism destination, the need to control incidences of infectious disease is considered a priority. Hence these countries are focusing on ways to improve diagnosis of diseases in high risk endemic areas.
"Vector borne diseases such as dengue and malaria were prevalent only in developing and emerging economies in Asia; however, blood borne diseases like HIV and Hepatitis are an issue in most of the Asia Pacific countries," says Frost & Sullivan Consultant Poornima Srinivasan. "Elimination strategies and national diagnosis policies focusing on microbiology testing and molecular testing are gaining grounds and these countries aim to be free from infectious disease by 2030."
The number of private hospitals and stand alone laboratories are expected to rise with ageing population and increased incidence of infectious disease. These factors drive the need for infectious disease diagnostic testing using sophisticated technologies.
Since the infectious disease diagnostics market is technology and price driven in most Asia Pacific countries, competitive pricing and relationship with distributors are the way forward for vendors in the market.
"Most countries are expected to adapt molecular diagnostic testing for blood borne infectious disease," opines Srinivasan. "It is likely that with huge research and development investments, multinational companies will continue to dominate the market after making an early entry in the molecular diagnostic segments for infectious diseases."
If you are interested in more information on this study, please send an e-mail with your contact details to Jessie Loh, Corporate Communications, at Jessie.firstname.lastname@example.org. You can register for the pre-recorded Analyst Briefing by clicking on the following link: http://www.frost.com/prod/servlet/analyst-briefing-detail.pag?mode=open&sid=260755979
For a virtual brochure of this study, go to:
Asia Pacific Infectious Disease Diagnostics Market is part of the Clinical Diagnostics Growth Partnership Services program. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – Asia Pacific
P: + 61 (02) 8247 8927
F: +61 (02) 9252 8066
Corporate Communications – Asia Pacific
P: +65 6890 0942
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved